We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Fig. 1

Fig. 1. From: The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes.

The relationship between metformin dose and cancer. The cancer occurrence rate mean was significantly lower in the low dose metformin group (<1,000 mg/day) compared to the high dose group (≥1,000 mg/day). aP<0.001.

Hyun Hee Chung, et al. Diabetes Metab J. 2013 April;37(2):125-131.

Supplemental Content

Filter your results:

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk